Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enrichment of CES1 Carriers in the Pharmacogenomics Anti-Platelet Intervention Study
NCT03188705Phase 4Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Oct 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel, aspirin in coronary artery disease (CAD), sponsored by University of Maryland, Baltimore. Started Oct 2019; status: completed.
02
Drugs
clopidogrelaspirin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03188705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03188705.